Cytokine Signalling Forum
Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:17
- Mas informaciones
Informações:
Sinopsis
Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers: baricitinib dose reduction in patients with RA achieving sustained disease control and switching to bDMARDs vs cycling among JAKis in patients with RA who are inadequate responders to JAKis.
